Clinerion Introduces New Services for Market Access
Clinerion has announced the release of its Patient Recruitment System Patient Finder tool for market access.
Clinerion has announced the release of its Patient Recruitment System Patient Finder tool for market access. This tool provides pharma companies with the ability to collect insight into patient populations and the prevalence of target diseases.
Read the full release here
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo
January 17th 2025Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a comparable safety and tolerability profile, further establishing its efficacy in obesity treatment.
